Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 725

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS

Mu, L, Feng, S.S·2003·Journal of Controlled Release
DOI 10.1016/s0168-3659(02)00320-6
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0168-3659(02)00320-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 32

  1. Yeh, 1996, Improving protein delivery from microparticles using blends of poly (d,l lactide-co-glycolide) and poly (ethylene oxide)-poly (propylene oxide) copolymers, Pharm. Res., 13, 1693, 10.1023/A:1016496824839 · DOI
  2. Jalil, 1990, Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties, J. Microencapsul., 7, 297, 10.3109/02652049009021842 · DOI · Paper page
  3. Brannon-Peppas, 1995, Recent advances in the use of biodegradable microparticles and nanoparticles in controlled drug delivery, Int. J. Pharm., 116, 1, 10.1016/0378-5173(94)00324-X · DOI · Paper page
  4. Maincent, 1986, Deposition kinetics and oral bioavailability of vincamin-loaded poly-alkyl cyanoacrylate nanoparticles, J. Pharm. Sci., 75, 955, 10.1002/jps.2600751009 · DOI
  5. Zeltner, 1991, Retention and clearance of 0.9-μm particles inhaled by hamsters during rest or exercise, J. Appl. Physiol., 70, 1137, 10.1152/jappl.1991.70.3.1137 · doi:10.1152/jappl.1991.70.3.1137
  6. Cappel, 1991, Effect of nanoparticles on transdermal drug delivery, J. Microencapsul., 8, 369, 10.3109/02652049109069563 · DOI
  7. Couvreur, 1977, Nanocapsules: a new type of lysosomotropic carrier, FEBS Lett., 84, 323, 10.1016/0014-5793(77)80717-5 · DOI · Paper page
  8. Astier, 1988, Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells, Cancer Res., 48, 1835
  9. Labhasetwar, 1997, Nanoparticle drug delivery system for restenosis, Adv. Drug Deliv. Rev., 24, 63, 10.1016/S0169-409X(96)00483-8 · DOI · Paper page
  10. Beck, 1993, Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models, J. Microencapsul., 10, 101, 10.3109/02652049309015316 · doi:10.3109/02652049309015316
  11. Simeonova, 1991, Nanoparticles as drug carriers for vinblastine. Acute toxicity of vinblastine in a free form and associated to polybutylcyanoacrylate nanoparticles, Acta Physiol. Pharmacol. Bulg., 17, 43
  12. Bennis, 1994, Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture, Eur. J. Cancer, 30A, 89, 10.1016/S0959-8049(05)80025-5 · DOI
  13. Verdun, 1990, Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles, Cancer Chemother. Pharmacol., 26, 13, 10.1007/BF02940287 · DOI
  14. Jain, 2000, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, 21, 2475, 10.1016/S0142-9612(00)00115-0 · DOI · Paper page
  15. Johansen, 2000, Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination, Eur. J. Pharm. Biopharm., 50, 129, 10.1016/S0939-6411(00)00079-5 · DOI · Paper page
  16. Singla, 2002, Paclitaxel and its formulations, Int. J. Pharm., 235, 179, 10.1016/S0378-5173(01)00986-3 · DOI · Paper page
  17. Tatou, 1996, Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation, Pharmacology, 52, 1, 10.1159/000139354 · doi:10.1159/000139354
  18. Dorr, 1994, Pharmacology and toxicology of Cremophor EL diluent, Ann. Pharmacother., 28, S11, 10.1177/10600280940280S503 · DOI · Paper page
  19. Fjallskog, 1993, Is cremophor, solvent for paclitaxel, cytotoxic?, Lancet, 342, 876, 10.1016/0140-6736(93)92735-C · DOI
  20. Webster, 1993, Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype, J. Natl. Cancer Inst., 85, 1685, 10.1093/jnci/85.20.1685 · DOI
  21. Mankad, 1992, Acute effects of cyclosporine and cremophor EL on endothelial function and vascular smooth-muscle in the isolated rat-heart, Cardiovasc. Drug Ther., 6, 77, 10.1007/BF00050920 · doi:10.1007/bf00050920
  22. Kongshaug, 1991, Interaction of Cremophor-EL with human plasma, Int. J. Biochem., 23, 473, 10.1016/0020-711X(91)90176-N · DOI
  23. Mu, 2002, Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®), J. Controlled Release, 80, 129, 10.1016/S0168-3659(02)00025-1 · DOI · Paper page
  24. Jeffery, 1991, The preparation and characterization of poly(lactide-co-glycolide) microparticles. 1. Oil-in-water emulsion solvent evaporation, Int. J. Pharm., 77, 169, 10.1016/0378-5173(91)90314-E · DOI · Paper page
  25. Scholes, 1993, The preparation of sub-200 nm poly(lactide-co-glycolyde) microspheres for site-specific drug delivery, J. Controlled Release, 25, 145, 10.1016/0168-3659(93)90103-C · DOI · Paper page
  26. Beck, 1979, A new long-acting injectable microcapsule system for the administration of progesterone, Fertil. Steril., 31, 545, 10.1016/S0015-0282(16)44002-1 · DOI · Paper page
  27. Wang, 1996, Preparation and characterization of poly (lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, Taxol, Chem. Pharm. Bull., 44, 1935, 10.1248/cpb.44.1935 · DOI
  28. Konan, 2002, Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles, Int. J. Pharm., 233, 239, 10.1016/S0378-5173(01)00944-9 · DOI · Paper page
  29. Murakami, 1997, Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(dl-lactide-co-glycolide) nanoparticle, Int. J. Pharm., 149, 43, 10.1016/S0378-5173(96)04854-5 · DOI
  30. Curvier, 1992, Doxorubicin-loaded nanospheres bypass tumour cell multidrug resistance, Biochem. Pharmacol., 44, 509, 10.1016/0006-2952(92)90443-M · DOI
  31. Verdun, 1990, Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles, Cancer Chemother. Pharmacol., 26, 13, 10.1007/BF02940287 · DOI
  32. Holland, 1992, Biodegradable Polymers, Vol. 6, 101

Cited by

See all 725

Metadata

Authors
Mu, L., & Feng, S. S.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2003-01
Volume
86
Issue
1
Pages
33-48
ISSN
0168-3659 (ISSN-L)
DOI
10.1016/s0168-3659(02)00320-6
OpenAlex
W2023409962
Cited by
725
References
2
FWCI
9.57
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. https://app.cochat.ai/papers/10.1016/s0168-3659(02)00320-6
The paper
Mu, L., & Feng, S. S. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. Journal of Controlled Release. https://doi.org/10.1016/s0168-3659(02)00320-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.